-
1061
-
1062
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
Published 2025-02-01Get full text
Article -
1063
MicroRNAs Expression Profile in MN1-Altered Astroblastoma
Published 2025-01-01Get full text
Article -
1064
Integrated proteogenomic characterization of ampullary adenocarcinoma
Published 2025-01-01Get full text
Article -
1065
Polygonatum kingianum polysaccharide alleviated intestinal injuries by mediating antioxidant ability and microbiota
Published 2025-01-01“…IntroductionPolygonatum kingianum is a well-known medicinal herb with proven bioactivities; however, little is known about the effects of its polysaccharide on intestinal injuries in animals induced by lipopolysaccharide (LPS).MethodsA total of 30 Institute of Cancer Research (ICR) mice were divided into control (CH), induced (MH), and treated (H) groups. …”
Get full text
Article -
1066
UK cancer vaccine advance – Recognising and realising opportunities
Published 2025-01-01Get full text
Article -
1067
-
1068
A conserved switch to less catalytically active Polycomb repressive complexes in non-dividing cells
Published 2025-01-01Get full text
Article -
1069
-
1070
-
1071
-
1072
-
1073
-
1074
-
1075
γδ T Cell‐mediated Tumor Immunity is Tightly Regulated by STING and TGF‐β Signaling Pathways
Published 2025-01-01Get full text
Article -
1076
-
1077
-
1078
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
Published 2025-01-01Get full text
Article -
1079
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials
Published 2024-03-01Get full text
Article -
1080
Dental and oral health assessments in the German National Cohort (NAKO)
Published 2025-01-01Get full text
Article